Final analysis of a cholesterol drug trial that was halted early was presented as a late-breaking clinical trial at the American Heart Association’s Scientific Sessions 2007.The ILLUMINATE trial was designed to test whether torcetrapib, in combination with atorvastatin, reduces major cardiovascular disease events when compared to atorvastatin alone.
